Fluicell Ab Stock Net Income
| FLUI Stock | SEK 13.00 1.40 12.07% |
As of the 25th of February, Fluicell shows the Mean Deviation of 4.44, downside deviation of 5.62, and Coefficient Of Variation of 3325.86. Fluicell AB technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Fluicell's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Fluicell's valuation are summarized below:Fluicell AB does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Fluicell |
Fluicell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fluicell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fluicell.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in Fluicell on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Fluicell AB or generate 0.0% return on investment in Fluicell over 90 days. Fluicell is related to or competes with Stayble Therapeutics, Guard Therapeutics, Prostatype Genomics, 2cureX AB, and Chordate Medical. Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications wor... More
Fluicell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fluicell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fluicell AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.62 | |||
| Information Ratio | 0.0142 | |||
| Maximum Drawdown | 34.82 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 12.07 |
Fluicell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fluicell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fluicell's standard deviation. In reality, there are many statistical measures that can use Fluicell historical prices to predict the future Fluicell's volatility.| Risk Adjusted Performance | 0.0319 | |||
| Jensen Alpha | 0.2783 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0161 | |||
| Treynor Ratio | (0.17) |
Fluicell February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0319 | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 4.44 | |||
| Semi Deviation | 4.96 | |||
| Downside Deviation | 5.62 | |||
| Coefficient Of Variation | 3325.86 | |||
| Standard Deviation | 6.37 | |||
| Variance | 40.61 | |||
| Information Ratio | 0.0142 | |||
| Jensen Alpha | 0.2783 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0161 | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 34.82 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 12.07 | |||
| Downside Variance | 31.63 | |||
| Semi Variance | 24.6 | |||
| Expected Short fall | (5.43) | |||
| Skewness | 1.18 | |||
| Kurtosis | 2.67 |
Fluicell AB Backtested Returns
Fluicell appears to be moderately volatile, given 3 months investment horizon. Fluicell AB secures Sharpe Ratio (or Efficiency) of 0.0794, which denotes the company had a 0.0794 % return per unit of risk over the last 3 months. By reviewing Fluicell's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please utilize Fluicell's Coefficient Of Variation of 3325.86, mean deviation of 4.44, and Downside Deviation of 5.62 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Fluicell holds a performance score of 6. The firm shows a Beta (market volatility) of -1.06, which means a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Fluicell are expected to decrease slowly. On the other hand, during market turmoil, Fluicell is expected to outperform it slightly. Please check Fluicell's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether Fluicell's price patterns will revert.
Auto-correlation | -0.49 |
Modest reverse predictability
Fluicell AB has modest reverse predictability. Overlapping area represents the amount of predictability between Fluicell time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fluicell AB price movement. The serial correlation of -0.49 indicates that about 49.0% of current Fluicell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Fluicell AB reported net income of (21.69 Million). This is 106.36% lower than that of the Healthcare sector and 130.97% lower than that of the Biotechnology industry. The net income for all Sweden stocks is 103.8% higher than that of the company.
Fluicell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fluicell's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fluicell could also be used in its relative valuation, which is a method of valuing Fluicell by comparing valuation metrics of similar companies.Fluicell is currently under evaluation in net income category among its peers.
Fluicell Fundamentals
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (8.62) % | |||
| Current Valuation | 49.13 M | |||
| Shares Outstanding | 24.49 M | |||
| Shares Owned By Insiders | 11.20 % | |||
| Shares Owned By Institutions | 0.67 % | |||
| Price To Book | 4.86 X | |||
| Price To Sales | 10.51 X | |||
| Revenue | 2.6 M | |||
| Gross Profit | 1.89 M | |||
| EBITDA | (21.08 M) | |||
| Net Income | (21.69 M) | |||
| Cash And Equivalents | 20.69 M | |||
| Cash Per Share | 1.45 X | |||
| Debt To Equity | 0.19 % | |||
| Current Ratio | 2.30 X | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | (18.64 M) | |||
| Earnings Per Share | (1.68) X | |||
| Number Of Employees | 19 | |||
| Beta | 1.96 | |||
| Market Capitalization | 73.64 M | |||
| Total Asset | 26.98 M | |||
| Net Asset | 26.98 M |
About Fluicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluicell AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluicell AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.